Cargando…
Transglutaminase 2—a novel inhibitor of adipogenesis
Differentiation of preadipocytes to lipid storing adipocytes involves extracellular signaling pathways, matrix remodeling and cytoskeletal changes. A number of factors have been implicated in maintaining the preadipocyte state and preventing their differentiation to adipocytes. We have previously re...
Autores principales: | Myneni, V D, Melino, G, Kaartinen, M T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558519/ https://www.ncbi.nlm.nih.gov/pubmed/26313919 http://dx.doi.org/10.1038/cddis.2015.238 |
Ejemplares similares
-
Factor XIII-A transglutaminase deficient mice show signs of metabolically healthy obesity on high fat diet
por: Myneni, Vamsee D., et al.
Publicado: (2016) -
Transglutaminases in Monocytes and Macrophages
por: Sun, Huifang, et al.
Publicado: (2018) -
Plasma Membrane Factor XIIIA Transglutaminase Activity Regulates
Osteoblast Matrix Secretion and Deposition by Affecting Microtubule
Dynamics
por: Al-Jallad, Hadil F., et al.
Publicado: (2011) -
Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis
por: Terrinoni, A, et al.
Publicado: (2012) -
A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis
por: Wang, Z, et al.
Publicado: (2013)